CD47-x-EpCAM-bispecific-antibody

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameCD47-x-EpCAM-bispecific-antibody
Drug Alias NameCD47-x-EpCAM-bispecific-antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEpithelial cell adhesion molecule inhibitors +[2] 
TargetsEpithelial cell adhesion moleculeCluster of differentiation 47
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirtuoso Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVirtuoso Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A